Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: A case report
نویسندگان
چکیده
منابع مشابه
Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177-DOTA-TATE treatment in Japan should be carried out according to this guideline. Although this gu...
متن کاملEsthesioneuroblastoma: a case report.
Esthesioneuroblastoma (olfactory neuroblastoma) is an uncommon neuroectodermal tumor. Its biological activity ranges from indolent growth to local recurrence and rapid widespread metastasis. Treatment options consist of surgical resection followed by radiation therapy for primary lesions and the addition of chemotherapy for advanced, recurrent, or metastatic lesions. Patients often present with...
متن کاملRAPID GROWING ESTHESIONEUROBLASTOMA 'Case Report)
Reported are the CT. clinicaland histological features of a case of rapid growing esthesioneuroblastoma with intracranial extension. This tumour is most frequently reported to grow slowly inside the nasal cavities and can extend to the paranasal sinuses. The case investigated here occurred initially as an intracranial. retroorbital and intrapalpebral tumour which appeared suddenly one day and r...
متن کاملCase Report of Huge Esthesioneuroblastoma
Esthesioneuroblastoma is a rare malignant tumor, account for only 1-5% of all malignant tumors of the paranasal sinuses; usually it presents with locally invasive disease, the delayed diagnosis of these tumors leads to tragic prognosis and bad results of surgery or conservative management. In this case, the diagnosis was too late in spite of followed up by medical doctors in deferent specialtie...
متن کاملComparison of receptor affinity of natSc-DOTA-TATE versus natGa-DOTA-TATE.
BACKGROUND 44Sc as a positron emitter can be an interesting alternative to 68Ga (T½=67.71 min) due to its longer half-life (T½=3.97 h). Moreover, the b-emitter 47Sc can be used for therapy when attached to the same biomolecule vectors. DOTA as a chelating agent has been proven suitable for the radiolabelling of peptides recognising tumour cell receptors in vivo with M3+ radiometals. DOTA-deriva...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental and Therapeutic Medicine
سال: 2016
ISSN: 1792-0981,1792-1015
DOI: 10.3892/etm.2016.3732